1. Home
  2. RR vs DTIL Comparison

RR vs DTIL Comparison

Compare RR & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Richtech Robotics Inc. Class B

RR

Richtech Robotics Inc. Class B

HOLD

Current Price

$1.67

Market Cap

614.9M

Sector

N/A

ML Signal

HOLD

Logo Precision BioSciences Inc.

DTIL

Precision BioSciences Inc.

HOLD

Current Price

$7.25

Market Cap

214.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RR
DTIL
Founded
2016
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
614.9M
214.7M
IPO Year
2023
2019

Fundamental Metrics

Financial Performance
Metric
RR
DTIL
Price
$1.67
$7.25
Analyst Decision
Hold
Strong Buy
Analyst Count
2
2
Target Price
$4.00
$45.00
AVG Volume (30 Days)
6.1M
243.3K
Earning Date
05-13-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,045,000.00
$1,070,000,000.00
Revenue This Year
$75.68
N/A
Revenue Next Year
$78.28
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.99
N/A
52 Week Low
$1.30
$3.53
52 Week High
$7.43
$9.62

Technical Indicators

Market Signals
Indicator
RR
DTIL
Relative Strength Index (RSI) 46.86 40.71
Support Level $1.54 $7.18
Resistance Level $1.83 $7.92
Average True Range (ATR) 0.13 0.40
MACD -0.01 -0.11
Stochastic Oscillator 30.68 5.61

Price Performance

Historical Comparison
RR
DTIL

About RR Richtech Robotics Inc. Class B

Richtech Robotics Inc is a robotics and artificial intelligence (AI) technology company focused on developing embodied AI systems that aims to improve the efficiency and productivity of businesses. The company trains proprietary artificial intelligence models on in-house data to operate robotic systems in the real world. It designs, engineers, manufactures, and deploys next generation embodied AI systems to serve a wide range of industries, including food service, retail, industrial manufacturing, automotive, healthcare, and hospitality. The company's offerings include Commercial Robotic Products, Industrial Robotic Products and Data Services. The company generated the majority of its revenue through product revenue (i.e. outright hardware sales).

About DTIL Precision BioSciences Inc.

Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).

Share on Social Networks: